Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 41
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Functional structure of local connections and differentiation of cerebral cortex areas in the neonate

  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Blanco Hinojo, Laura, 1981-
  • Persavento, C.
  • Martinez Vilavella, Gerard|||0000-0001-8948-4918
  • Falcon, Carles
  • Gascon, Mireia|||0000-0003-4537-8472
  • Rivas Lara, Ioar|||0000-0002-4743-619X
  • Vilanova, M.
  • Deus Yela, Juan|||0000-0002-3305-2662
  • Domingo Gispert, Juan
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Llurba, Elisa|||0000-0003-4048-6407
  • Dadvand, Payam|||0000-0002-2325-1027
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
Neuroimaging research on functional connectivity can provide valuable information on the developmental differentiation of the infant cerebral cortex into its functional areas. We examined healthy neonates to comprehensively map brain functional connectivity using a combination of local measures that uniquely capture the rich spatial structure of cerebral cortex functional connections. Optimal functional MRI scans were obtained in 61 neonates. Local functional connectivity maps were based on Iso-Distance Average Correlation (IDAC) measures. Single distance maps and maps combining three distinct IDAC measures were used to assess different levels of cortical area functional differentiation. A set of brain areas showed higher connectivity than the rest of the brain parenchyma in each local distance map. These areas were consistent with those supporting basic aspects of the neonatal repertoire of adaptive behaviors and included the sensorimotor, auditory and visual cortices, the frontal operculum/anterior insula (relevant for sucking, swallowing and the sense of taste), paracentral lobule (processing anal and urethral sphincter activity), default mode network (relevant for self-awareness), and limbic-emotional structures such as the anterior cingulate cortex, amygdala and hippocampus. However, the results also indicate that brain areas presumed to be actively developing may not necessarily be mature. In fact, combined distance, second-level maps confirmed that the functional differentiation of the cerebral cortex into functional areas in neonates is far from complete. Our results provide a more comprehensive understanding of the developing brain systems, while also highlighting the substantial developmental journey that the neonatal brain must undergo to reach adulthood.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications, a systematic review and meta-analysis

  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Vázquez, Juan Carlos
  • Ullmo, Johana|||0000-0002-9313-917X
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Evidence on the impact of low-molecular-weight heparin, alone or in combination with low-dose aspirin, for the prevention for preeclampsia in high-risk patients is conflicting. Objective: We conducted a meta-analysis of studies published to assess the effectiveness of low-molecular-weight heparin for the prevention of preeclampsia and other placenta-related complications in high-risk women. Data Sources: A systematic search was performed to identify relevant studies, using the databases PubMed and Cochrane Central Register of Controlled Trials, without publication time restrictions. Study Eligibility Criteria: Randomized controlled trials comparing treatment with low-molecular-weight heparin or unfractionated heparin (with or without low-dose aspirin), in high-risk women, defined as either history of preeclampsia, intrauterine growth restriction, fetal demise, or miscarriage or being at high risk after first-trimester screening of preeclampsia. Study Appraisal and Synthesis Methods: The systematic review was conducted according to the Cochrane Handbook guidelines. The primary outcome was the development of preeclampsia. We performed prespecified subgroup analyses according to combination with low-dose aspirin, low-molecular-weight heparin type, gestational age when treatment was started, and study population (patients with thrombophilia, at high risk of preeclampsia or miscarriage). Secondary outcomes included small for gestational age, perinatal death, miscarriage, and placental abruption. Pooled odds ratios with 95% confidence intervals were calculated using a random-effects model. Quality of evidence was assessed using the grading of recommendations assessment, development, and evaluation methodology. Results: A total of 15 studies (2795 participants) were included. In high-risk women, treatment with low-molecular-weight heparin was associated with a reduction in the development of preeclampsia (odds ratio, 0.62; 95% confidence interval, 0.43-0.90; P=.010); small for gestational age (odds ratio, 0.61; 95% confidence interval, 0.44-0.85; P=.003), and perinatal death (odds ratio, 0.49; 95% confidence interval, 0.25-0.94; P=.030). This reduction was stronger if low-molecular-weight heparin was started before 16 weeks' gestation (13 studies, 2474 participants) for preeclampsia (odds ratio, 0.55; 95% confidence interval, 0.39-0.76; P=.0004). When only studies including low-dose aspirin as an intervention were analyzed (6 randomized controlled trials, 920 participants), a significant reduction was observed in those with combined treatment (low-molecular-weight heparin plus low-dose aspirin) compared with low-dose aspirin alone (odds ratio, 0.62; 95% confidence interval, 0.41-0.95; P=.030). Overall, adverse events were neither serious nor significantly different. Quality of evidence ranged from very low to moderate, mostly because of the lack of blinding, imprecision, and inconsistency. Conclusion: Low-molecular-weight heparin use was associated with a significant reduction in the risk of preeclampsia and other placenta-mediated complications in high-risk women and when treatment was started before 16 weeks' gestation. Combined treatment with low-dose aspirin was associated with a significant reduction in the risk of preeclampsia compared with low-dose aspirin alone. However, there exists important clinical and statistical heterogeneity, and therefore, these results merit confirmation in large well-designed clinical trials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy

  • Ullmo, Johana|||0000-0002-9313-917X
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Bos-Real, L.|||0000-0002-6159-0644
  • Padilla-Lopez, Mireia|||0000-0002-4374-3870
  • Coma-Barbarà, Marina
  • Martorell, Silvia
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Women diagnosed with pre-eclampsia (PE), especially those with early-onset and severe forms, are at heightened risk of future cardiovascular disease (CVD). It is uncertain if women at high-risk for PE present cardiovascular impairment at the beginning of pregnancy. The aim of this study was to assess cardiovascular biomarkers and cardiac function in the first half of pregnancy in women at high-risk for PE. Methods: This was a prospective cohort study including women attending first trimester screening for PE. Risk of PE in the first trimester was calculated using a previously validated model, which includes maternal factors and biophysical markers. A cut-off of 1 in 250 was used to classify high-risk for developing PE. Maternal echocardiographic function and morphometry were evaluated, and peripheral blood samples were obtained to assess hematological and biochemical variables, including lipid profile and cardiovascular and angiogenic factors. Results: A total of 349 pregnant individuals were included; 257 at high-risk and 92 at low-risk for PE. Maternal echocardiography was performed at a mean ± SD gestational age of 14.9 ± 1.3 weeks and blood sampling at 16.3 ± 1.9 weeks. The high-risk PE group exhibited a significantly worse lipid profile (lower levels of high-density lipoproteins 69.7 ± 14.2 vs 74.0 ± 14.6 mg/dL, p=0.020), lower placental growth factor (0.89 ± 0.63 vs 1.15 ± 0.58 MoM, p<0.001), and significantly lower levels of N-terminal pro-brain natriuretic peptide (51.0 ± 2.1 vs 52.1 ± 2.0 ng/L, p=0.008). Echocardiographic evaluation indicated concentric remodeling, along with an altered diastolic pattern in the high-risk group. Conclusions: Women at high risk of developing PE exhibit differences in lipid profile, angiogenic factors, and echocardiographic parameters, indicative of cardiac maladaptation or impairment during the first half of pregnancy. These findings suggest a link between subclinical cardiovascular dysfunction, PE development and later CVD risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mapping of Determinants of Urinary Sex Steroid Metabolites During Late Pregnancy, Results from Two Spanish Cohorts

  • Laveriano-Santos, E.P.|||0000-0002-4852-6074
  • Renard Dausset, Estelle|||0009-0008-1258-090X
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Pelegrí-Sisó, Dolors|||0000-0002-5993-3003
  • García Ruiz, Zoraida|||0009-0009-4631-763X
  • Ruiz-Rivera, Marina|||0009-0004-4537-8944
  • Cosin-Tomas, Marta|||0000-0001-5012-8983
  • Llurba, Elisa|||0000-0003-4048-6407
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Haro, Noemí
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Dadvand, Payam|||0000-0002-2325-1027
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Maitre, Léa|||0000-0003-3682-7117
Steroid hormones (SHs), including sex steroids and corticosteroids, are crucial for a healthy pregnancy. We aimed to comprehensively characterize the maternal SH metabolome in late pregnancy and identify clinical, lifestyle, and sociodemographic determinants influencing SH metabolism with a replication in an independent cohort. Urinary SH metabolites were analyzed in 1221 third-trimester pregnant women (aged 28 to 37 years) from two Spanish cohorts, BiSC (2018-2021, n = 721) and INMA-Sabadell (2004-2006, n = 500), using targeted UHPLC-MS/MS. We quantified 50 SH metabolites, resulting in 13 hormone groups, 9 sulfate/glucuronide ratios, and 17 estimated steroid enzymatic activities across steroidogenesis pathways. We applied elastic net regression to identify determinants, and multivariable linear regression models to estimate variance explained. Among the 47 and 28 determinants from BiSC and INMA-Sabadell, respectively, 10 determinant-SH metabolome pairs showed statistically significant associations (p < 0.05), supporting robust replication. Maternal BMI was the main determinant linked to higher corticosteroid and androgen metabolites. Higher physical activity was associated with lower glucocorticoids and progestogen metabolites, while older maternal age was related with lower levels of androgen and corticosteroid metabolites. Tobacco exposure in the first trimester predicted higher levels of cortisol metabolites. Latin American women had lower cortolone levels compared with Spanish women. Parity, dietary fat intake, sleep, alcohol intake, and sex of the fetus contributed to smaller variations in different SHs. This dual-cohort analysis provides the most detailed and replicated evidence to date of how clinical, lifestyle, and sociodemographic factors shape the maternal SH metabolome during late pregnancy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Air pollution and fetal brain morphological development, a prospective cohort study

  • Eixarch, Elisenda|||0000-0001-7379-9608
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Cirach, Marta
  • Nieuwenhuijsen, Mark|||0000-0001-9461-7981
  • Basagaña, X.|||0000-0002-8457-1489
  • Querol, Xavier
  • Foraster, Maria|||0000-0003-4450-4123
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Gascon, Mireia|||0000-0003-4537-8472
  • Llurba, Elisa|||0000-0003-4048-6407
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Dadvand, Payam|||0000-0002-2325-1027
  • Sunyer, Jordi
  • Gómez Herrera, Laura|||0000-0002-5929-8409
  • Zhao, Yu
  • Rivas Lara, Ioar|||0000-0002-4743-619X
  • Galmes, Toni
  • Muniesa, Marta
  • Zanini, Julia|||0000-0002-6006-7595
  • Domínguez, Alan
Background: There is a scarcity of evidence of the influence of exposure to air pollution during pregnancy on the human fetal brain characterised prenatally. We aimed to evaluate the association of exposure to air pollution with fetal brain morphology. Methods: In this prospective cohort study, we used data from the Barcelona Life Study Cohort, Spain, which recruited 1080 pregnant women at 8-14 weeks of gestation between Oct 16, 2018, and April 14, 2021, from three major university hospitals in Barcelona. Eligible participants were aged 18-45 years, had a singleton pregnancy, and had a fetus without major congenital anomalies. Third-trimester transvaginal neurosonography was applied to evaluate fetal brain morphological development. We integrated comprehensive data on time-activity patterns with land use regression, dispersion, and hybrid models to estimate exposure to NO, PM, and black carbon at home, workplace, and commuting routes during pregnancy until the neurosonography date. Single-pollutant linear mixed regression models and multipollutant ridge regression models were applied to estimate the associations between air pollutants and fetal brain outcomes, controlled for confounders. Distributed lag linear models were used to identify the vulnerable windows. Findings: Among 1080 participants recruited at baseline, 954 attended the follow-up for the neurosonographic examination, 754 of whom were included in this study. In single-pollutant models, we found that prenatal exposure to NO, PM, and black carbon was associated with a wider anterior horn of lateral ventricles, wider cisterna magna, and larger cerebellar vermis. We also observed that higher exposure to black carbon was related to a shallower Sylvian fissure. No clear pattern or associations were observed between air pollution and other structures of brain morphology. Multipollutant models showed that these associations with black carbon remained significant, whereas associations with PM and NO lost significance for some indicators. A potential vulnerability window in mid-to-late pregnancy was identified for these associations. Interpretation: Exposure to air pollution might affect brain morphological development as early as the fetal stage. Our findings could have important policy implications as they highlight the need to mitigate exposure of pregnant individuals to air pollution in urban areas to protect fetal brain development. Funding: European Research Council.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of in utero exposure to phthalate and DINCH metabolites with placental DNA methylation

  • Vespalcova, Hana|||0000-0003-0404-3166
  • Knox, B.|||0000-0001-5870-9344
  • Sakhi, Amrit K.|||0000-0002-2918-323X
  • Thomsen, C.|||0000-0002-6889-7868
  • Cosin-Tomas, Marta|||0000-0001-5012-8983
  • Gómez Herrera, Laura|||0000-0002-5929-8409
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Llurba, Elisa|||0000-0003-4048-6407
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Dadvand, Payam|||0000-0002-2325-1027
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Aguilar-Lacasaña, S.|||0000-0002-7953-1589
Phthalates and DINCH are non-persistent chemicals widely used in consumer products. In utero exposure to these compounds has been linked to adverse reproductive and long-term health outcomes, potentially through epigenetic changes in the placenta. This study investigated associations between maternal phthalate and DINCH metabolite levels and placental DNA methylation in 469 mother-child pairs from the Barcelona Life Study Cohort (BiSC). Fifteen phthalate and two DINCH metabolites were measured in pooled maternal urine samples collected at 19 and 35 weeks of gestation using liquid chromatography-tandem mass spectrometry (LC-MS/MS. Placental DNA methylation was assessed using the Illumina EPIC array. We applied robust linear regression models to test associations between single exposures at 19 weeks, 35 weeks, and whole pregnancy (average of the two time points), with each CpG site. In secondary analyses, quantile g-computation was used to test associations between exposure mixtures and suggestive CpGs (p-value < 1E-05). We identified 38 Bonferroni significant associations in the single exposure models (p-value < 1E-07)- 24 at 19 weeks, 8 at 35 weeks and 6 for the whole pregnancy period. Suggestive CpGs (p-value < 1E-05) were annotated to genes involved in metabolic, immune and vascular pathways, steroid biosynthesis, and sex hormone signaling. Sex-stratified analyses revealed 49 female-specific and 42 male-specific associations, most of which were identified at a single time point. Mixture analyses revealed 20 significant associations, all consistent in direction with the single-metabolite models. These results suggest that prenatal exposure to phthalates and DINCH may contribute to placental epigenetic alterations supporting a role for endocrine disruption, metabolism, and vascular and immune modulation in mediating their effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dietary patterns and exposure to non-persistent endocrine-disrupting chemicals during pregnancy

  • Warkentin, Sarah|||0000-0002-6678-5256
  • Márquez, Sandra
  • Gascon, Mireia|||0000-0003-4537-8472
  • Güil-Oumrait, Nuria|||0000-0003-4097-7038
  • González-Palacios, Sandra|||0000-0003-3358-472X
  • Lassale, Camille|||0000-0002-9340-2708
  • Llurba, Elisa|||0000-0003-4048-6407
  • Rolland, Matthieu|||0000-0002-8076-5550
  • Sakhi, Amrit K.|||0000-0002-2918-323X
  • Thomsen, C.|||0000-0002-6889-7868
  • Vioque, Jesús|||0000-0002-2284-148X
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Vespalcova, Hana|||0000-0003-0404-3166
  • Knox, Bethany
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
Background: Exposure to non-persistent endocrine disrupting chemicals (EDCs) is widespread, causing various adverse health effects, especially during pregnancy. Diet is a major source of EDCs and the identification of dietary patterns that give rise to higher exposure levels is crucial. We aimed to explore the relationship between dietary patterns during pregnancy and exposure to non-persistent EDCs. Methods: We included 640 pregnant women from the Barcelona Life Study Cohort (BiSC), Spain. Using food frequency questionnaires (2nd trimester), we estimated ultraprocessed food (UPF) consumption and Mediterranean diet adherence, and derived data-driven dietary patterns. Metabolites of phthalates, 1,2-cyclohexane dicarboxylic acid di(isononyl) ester (DINCH), chlorpyrifos and pyrethroid, polycyclic aromatic hydrocarbons (PAHs, including phenanthrenes), and organophosphates, and parent compounds of phenols and parabens were measured in weekly urine pools (3rd trimester). Associations between dietary patterns and EDCs were evaluated through multivariable linear regressions. Results: Higher compliance with a "Vegetarian" pattern or the Mediterranean diet was associated with lower levels of some of the phthalate metabolites (e.g., di-iso-nonyl phthalates [Geometric mean ratio (GMR) per unit increases in the "Vegetarian" score = 0.97, 95 %CI 0.95, 1.00]). Conversely, "Western" and "Animal protein" patterns, and UPF intake were associated with higher PAHs (e.g., "Western" and 2-Hydroxynaphthalene [GMR(95 %CI) 1.07(1.01, 1.13)]), pesticides (e.g., "Animal protein" and 3-Phenoxybenzoic acid [1.15(1.01, 1.32]), and phthalates metabolites levels (e.g., UPF and Monoethyl phthalate [1.05(1.01, 1.09)]). No association remained significant after correcting for multiple testing. Conclusions: Following a plant-based diet may help reduce the exposure to certain phthalate and organophosphate metabolites, whereas higher consumption of foods from animal origin and high in fat/sugar/salt may increase exposure to PAHs, pesticides, and phthalates metabolites in pregnancy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prenatal phenol exposure and child behaviour, insights into the hypothalamic-pituitary-adrenal axis from two prospective mother-child cohorts

  • Rolland, Matthieu|||0000-0002-8076-5550
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Jedynak, Paulina|||0000-0002-9525-8308
  • Thomsen, Cathrine
  • Sakhi, Amrit K.|||0000-0002-2918-323X
  • Foraster, Maria|||0000-0003-4450-4123
  • Gascon, Mireia|||0000-0003-4537-8472
  • Llurba, Elisa|||0000-0003-4048-6407
  • Rivas Lara, Ioar|||0000-0002-4743-619X
  • Ferrer, Muriel
  • Bayat, Sam|||0000-0002-8565-0293
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Sunyer, Jordi
  • Slama, Rémy
  • Dadvand, Payam|||0000-0002-2325-1027
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Ouellet-Morin, Isabelle
  • Morillas, Alex
  • Carras, Sylvain
  • Lyon-Caen, Sarah
  • Philippat, Claire
Background: Synthetic phenols are widely used chemicals with potential neurodevelopmental toxicity. Human studies are often limited by small sample sizes and exposure misclassification. Identifying the biological pathways affected by these substances is crucial for understanding key drivers of toxicity. We aimed to study associations between prenatal exposure to synthetic phenols and child behaviour, exploring the potential mediating role of maternal steroid hormones.MethodsWe pooled data from two European cohorts: the Barcelona Life Study Cohort (BiSC; Barcelona, Spain, 2018-21, N=1080) and Suivi de l'Exposition à la Pollution Atmosphérique durant la Grossesse et Effets sur la Santé (SEPAGES; Grenoble, France, 2014-17, N=484). Mothers older than 18 years having a singleton pregnancy of less than 19 weeks gestational age were eligible for inclusion in the cohorts; those having multiple pregnancies were excluded. Repeated urine samples (up to 24 in BiSC; up to 42 in SEPAGES) collected in the second and third trimesters were pooled and analysed for 12 synthetic phenols. Child behavioural outcomes were assessed at 18 months in BiSC and 24 months in SEPAGES using the Child Behavior Checklist for Ages 1·5-5 (CBCL). Concentrations of total cortisol, total cortisone, and 11-dehydrocorticosterone-steroid hormones involved in the hypothalamic-pituitary-adrenal axis-were measured from maternal hair samples. Associations between phenol exposure and behavioural outcomes were estimated by adjusted linear regression analysis, and mediation by steroid hormones was assessed with regression-based causal mediation analysis within the counterfactual framework.Findings1024 mother-child pairs were included in the study: 607 from BiSC and 417 from SEPAGES. Maternal exposure to methylparaben in the third trimester of pregnancy was associated with higher internalising scores (change in score of 0·44 [95% CI 0·10-0·79] points) and externalising scores (0·67 [0·12-1·24]) in the CBCL. In boys, maternal exposure to bisphenol S in the third trimester was linked to increased internalising scores (0·92 [0·15 to 1·75]; p=0·019) and could be linked to increased externalising scores (1·14 [−0·09 to 2·44]; p=0·070). In girls, second-trimester butylparaben and propylparaben exposure were associated with lower internalising (−1·03 [−1·84 to −0·09], p=0·033) and externalising (−0·68 [−1·23 to −0·12]; p=0·019) scores. No mediation by steroid hormones was observed.InterpretationPrenatal exposure to phenols might influence early behavioural development, with sex-specific patterns. There was no strong evidence of mediation by maternal steroid hormones, suggesting the involvement of alternative pathways in the biological effects of phenols. Together with previous findings, these results highlight the need for stricter regulation of these compounds to reduce prenatal exposure.FundingFrench Agency for Food, Environmental and Occupational Health & Safety, the EU's Horizon 2020 research and innovation programme, and the French Fund - Fondation de France.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications

  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Universitat Autònoma de Barcelona.
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Platero, Judit|||0000-0001-6007-9855
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • García Manau, Pablo|||0000-0002-2415-1626
  • Ullmo, Johana|||0000-0002-9313-917X
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Vila-Cortés, M.
  • Pelegay, M. J.
  • Ricart, M
  • Muñoz-Abellana, B.
  • Barrios, X. Gabaldó
Objective: A soluble fms-like tyrosine kinase-1 (sFlt-1)-to-placental growth factor (PlGF) ratio cut-off of 38 is currently considered optimal for ruling out pre-eclampsia (PE); however, implementation of this ratio in clinical practice is limited. N-terminal pro B-type natriuretic peptide (NT-proBNP) is elevated in PE owing to the cardiovascular effects of this disease. This study aimed to identify the predictive performance of NT-proBNP to detect PE and placental complications within 1 week after assessment, and compare it with the predictive performance of the sFlt-1/PlGF ratio. High-sensitivity troponin T (hs-TnT) and uric acid were also evaluated. Methods: This was a prospective nested case-control study conducted in five Spanish centers between March 2018 and December 2020, and comprised women with a singleton pregnancy and suspected PE between 24 + 0 and 41 + 0 weeks' gestation. We evaluated the ability of the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid to predict the development of any-onset (at any gestational age), early-onset (before 34 weeks) or term (at or after 37 weeks) PE within 1 week or 4 weeks after assessment. Predictive performance was assessed by estimating negative predictive values, positive predictive values, sensitivity, specificity and areas under the receiver-operating-characteristics curves (AUCs) for these biomarkers, with corresponding 95% CIs. We performed post-hoc exploratory analyses of associations between the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid in women who developed PE, as well as in women who developed complicated PE (PE plus fetal growth restriction, stillbirth or placental abruption) within 1 week and 4 weeks after assessment. Results: A total of 323 women with suspected PE at or before 41 + 0 weeks were enrolled in the study, of whom seven were lost to follow-up. The final analysis included 316 eligible participants, with 424 samples. The overall incidence of PE was 23.4% (n = 74) and early-onset PE developed in 8.5% (n = 27) of cases. The sFlt-1/PlGF ratio and NT-proBNP exhibited similar abilities to predict early-onset PE within 1 week after assessment (AUC, 0.970 (95% CI, 0.932-1.000) and 0.971 (95% CI, 0.942-1.000), respectively). hs-TnT and uric acid demonstrated inferior predictive capability compared with the sFlt-1/PlGF ratio for the prediction of any-onset PE, early-onset PE and term PE within 1 week and 4 weeks after assessment. The optimal cut-off for NT-proBNP was 116 pg/mL. At this cut-off, NT-proBNP showed a sensitivity of 90.9% (95% CI, 70.8-98.9%) and a specificity of 94.3% (95% CI, 91.2-96.5%), with a positive predictive value of 5.7% (95% CI, 3.7-8.7%) and a negative predictive value of 99.9% (95% CI, 99.9-100%) in predicting early-onset PE within 1 week of assessment, which was comparable with that of the sFlt-1/PlGF ratio. Participants with PE-related complications had higher levels of all biomarkers, but only NT-proBNP showed a similar predictive ability to the sFlt-1/PlGF ratio for complicated PE within 1 week after assessment (AUC, 0.818 (95% CI, 0.706-0.930) vs 0.822 (95% CI, 0.723-0.921), respectively). Conclusion: An NT-proBNP cut-off value of 116 pg/mL has a similar diagnostic performance to that of the sFlt-1/PlGF ratio in predicting the diagnosis of early-onset PE within 1 week after assessment. Thus, NT-proBNP could be used in clinical practice for the early identification and management of PE, particularly in cases for which the sFlt-1/PlGF ratio is not available. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cardiometabolic risk through an integrative classification combining physical activity and sedentary behavior in European adolescents: HELENA study

  • Cristi-Montero, C.
  • Chillón, P.
  • Labayen, I.
  • Casajus, J.A.
  • Gonzalez-Gross, M.
  • Vanhelst, J.
  • Manios, Y.
  • Moreno, L.A.
  • Ortega, F.B.
  • Ruiz, J.R.
Purpose: This study aims to compare adolescents’ cardiometabolic risk score through an integrative classification of physical activity (PA), which involves the combination of moderate-to-vigorous physical activity (MVPA) and sedentary behavior (SB). Methods: A cross-sectional study derived from the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study database (2006–2008) was conducted in adolescents (n = 548; boys, 47.3%; 14.7 ± 1.2 years) from 10 European cities. MVPA and SB were objectively measured using accelerometry. Adolescents were divided into 4 categories according to MVPA (meeting or not meeting the international recommendations) and the median of SB time (above or below sex- and age-specific median) as follows: High-SB & Inactive, Low-SB & Inactive, High-SB & Active, and Low-SB & Active. A clustered cardiometabolic risk score was computed using the homeostatic model assessment, systolic blood pressure, triglycerides, total cholesterol/high-density lipoprotein cholesterol, sum 4 skinfolds, and cardiorespiratory fitness (CRF). Analyses of covariance were performed to discern differences on cardiometabolic risk scores among PA categories and each health component. Results: The cardiometabolic risk score was lower in adolescents meeting the MVPA recommendation and with less time spent in SB in comparison to the high-SB & inactive group (p < 0.05). However, no difference in cardiometabolic risk score was established between high-SB or low-SB groups in inactive adolescents. It is important to note that CRF was the only variable that showed a significant modification (higher) when children were compared from the category of physically inactive with “active” but not from high-to low-SB. Conclusion: Being physically active is the most significant and protective outcome in adolescents to reduce cardiometabolic risk. Lower SB does not exhibit a significant and extra beneficial difference.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Correlates of ideal cardiovascular health in European adolescents: The HELENA study

  • Henriksson, P.
  • Henriksson, H.
  • Labayen, I.
  • Huybrechts, I.
  • Gracia-Marco, L.
  • Ortega, F.B.
  • Espana-Romero, V.
  • Manios, Y.
  • Gonzalez-Gross, M.
  • Marcos, A.
  • Moreno, L.A.
  • Gutierrez, A.
  • Ruiz, J.R.
Background and aims: The ideal cardiovascular health (iCVH) construct consists of 4 health behaviors (smoking status, body mass index, physical activity and diet) and 3 health factors (total cholesterol, blood pressure and fasting glucose). A greater number of iCVH components in adolescence are related to better cardiovascular health, but little is known about the correlates of iCVH in adolescents. Thus, the aim of the study was to examine correlates of iCVH in European adolescents. Methods and results: The study comprised 637 European adolescents with complete iCVH data. Participants were part of the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study, a cross-sectional, multicenter study conducted in 9 different European countries. Correlates investigated were sex and age, family affluence scale, maternal education, geographic location, sleep time, television viewing, duration of pregnancy, birth weight and breastfeeding. Younger adolescents, those whose mothers had medium/high education or those whowatched television less than 2 h per day had a greater number of iCVH components compared to those who were older, had a mother with low education or watched television 2 h or more daily (P <= 0.01). Conclusion: Since in our study older adolescents had worse iCVH than younger adolescents, early promotion of cardiovascular health may be important. Future studies mayalso investigate the usefulness of limiting television viewing to promote iCVH. Finally, since adolescents of mothers with low education had poorer iCVH, it may be of special interest to tailor public health promotion to adolescents from families with low socioeconomic status.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Muscular fitness mediates the association between 25-hydroxyvitamin D and areal bone mineral density in children with overweight/obesity

  • Gil-Cosano, José J.
  • Gracia-Marco, Luis
  • Ubago-Guisado, Esther
  • Migueles, Jairo H.
  • Mora-González, José
  • Escolano-Margarit, María V.
  • Gómez-Vida, José
  • Maldonado, José
  • Ortega, Francisco B.
The association between vitamin D [25(OH)D] and bone health has been widely studied in children. Given that 25(OH)D and bone health are associated with muscular fitness, this could be the cornerstone to understand this relationship. Hence, the purpose of this work was to examine if the relation between 25(OH)D and areal bone mineral density (aBMD) was mediated by muscular fitness in children with overweight/obesity. Eighty-one children (8-11 years, 53 boys) with overweight/obesity were included. Body composition was measured with dual energy X-ray Absorptiometry (DXA), 25(OH)D was measured in plasma samples and muscular fitness was assessed by handgrip and standing long jump tests (averaged z-scores were used to represent overall muscular fitness). Simple mediation analyses controlling for sex, years from peak height velocity, lean mass and season were carried out. Our results showed that muscular fitness z-score, handgrip strength and standing long jump acted as mediators in the relationship between 25(OH)D and aBMD outcomes (percentages of mediation ranged from 49.6% to 68.3%). In conclusion, muscular fitness mediates the association of 25(OH)D with aBMD in children with overweight/obesity. Therefore, 25(OH)D benefits to bone health could be dependent on muscular fitness in young ages.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Dairy consumption at snack meal occasions and the overall quality of diet during childhood. Prospective and cross-sectional analyses from the IDEFICS/I.Family cohort

  • Iglesia, Iris
  • Intemann, Timm
  • De Miguel-Etayo, Pilar
  • Pala, V.
  • Hebestreit, A.
  • Wolters, M.
  • Russo, P.
  • Veidebaum, T.
  • Papoutsou, S.
  • Nagy, P.
  • Eiben, G.
  • Rise, P.
  • De Henauw, S.
  • Moreno, Luis A.
  • on behalf of the IDEFICS, /I.Family consortia
There is scarce information on the influence of dairy consumption between main meals on the overall diet quality through childhood, constituting the main aim of this research. From the Identification and prevention of Dietary-and lifestyle induced health EFfects In Children and infantS (IDEFICS) study, and based on the data availability in each period due to drop outs, 8807 children aged 2 to 9.9 years from eight European countries at baseline (T0: 2007–2008); 5085 children after two years (T1); and 1991 after four years (T3), were included in these analyses. Dietary intake and the Diet Quality Index (DQI) were assessed by two 24 hours dietary recalls (24-HDR) and food frequency questionnaire. Consumption of milk and yogurt (p = 0.04) and cheese (p < 0.001) at snack meal occasions was associated with higher DQI scores in T0; milk and yogurt (p < 0.001), and cheese (p < 0.001) in T1; and cheese (p = 0.05) in T3. Consumers of milk (p = 0.02), yogurt (p < 0.001), or cheese (p < 0.001) throughout T0 and T1 at all snack moments had significantly higher scores of DQI compared to non-consumers. This was also observed with the consumption of cheese between T1 and T3 (p = 0.03). Consumption of dairy products at snack moments through childhood is associated with a better overall diet quality, being a good strategy to improve it in this period.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The evolving microbiome from pregnancy to early infancy: A comprehensive review

  • Mesa, María D.
  • Loureiro, Begoña
  • Iglesia, Iris
  • Fernandez Gonzalez, Sergi
  • Llurba Olivé, Elisa
  • García Algar, Oscar
  • Solana, María J.
  • Cabero Perez, Mª J.
  • Sainz, Talia
  • Martinez, Leopoldo
  • Escuder-Vieco, Diana
  • Parra-Llorca, Anna
  • Sánchez-Campillo, María
  • Rodriguez Martinez, Gerardo
  • Gómez Roig, Dolores
  • Perez Gruz, Myriam
  • Andreu-Fernández, Vicente
  • Clotet, Jordi
  • Sailer, Sebastian
  • Iglesias-Platas, Isabel
  • López-Herce, Jesús
  • Aras, Rosa
  • Pallás-Alonso, Carmen
  • de Pipaon, Miguel S.
  • Vento, Máximo
  • Gormaz, María
  • Larqué Daza, Elvira
  • Calvo, Cristina
  • Cabañas, Fernando
Pregnancy induces a number of immunological, hormonal, and metabolic changes that are necessary for the mother to adapt her body to this new physiological situation. The microbiome of the mother, the placenta and the fetus influence the fetus growth and undoubtedly plays a major role in the adequate development of the newborn infant. Hence, the microbiome modulates the inflammatory mechanisms related to physiological and pathological processes that are involved in the perinatal progress through different mechanisms. The present review summarizes the actual knowledge related to physiological changes in the microbiota occurring in the mother, the fetus, and the child, both during neonatal period and beyond. In addition, we approach some specific pathological situations during the perinatal periods, as well as the influence of the type of delivery and feeding.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Reseña (Review)

Relative validity of food frequency questionnaires to assess food items, energy, macronutrient and micronutrient intake in children and adolescents: A systematic review with meta-analysis

  • Saravia, L.
  • Miguel-Berges, M.L.
  • Iglesia, I.
  • Nascimento-Ferreira, M.V.
  • Perdomo, G.
  • Bove, I.
  • Slater, B.
  • Moreno, L.A.
Food Frequency Questionnaires (FFQs) are one of the most widely used tools of research into nutritional epidemiology, and many studies have been conducted in several countries using this dietary assessment method. This study aimed to evaluate the relative validity of FFQs, in comparison with other methods, in assessing dietary intake of children and adolescents, through a systematic review. Four electronic databases (Embase, PubMed, Scopus and Web of Science) found 67 articles, which met the inclusion criteria (healthy children and adolescents from 3 to 18 years; journal articles written in English, Spanish and Portuguese between 1988 and March 2019; results showing the comparison between the FFQ with other methods of assessment of dietary intake). The articles were analyzed by two independent reviewers. A meta-analysis was conducted using correlation coefficients as estimate effects between the FFQ and the reference standard method. Subgroup analysis and meta-regression were performed to identify the probable source of heterogeneity. In 55 of the 67 studies, a single dietary assessment method was used to evaluate the FFQ; 9 combined the two methods and 3 used three reference methods. The most widely used reference method was the 24-Hour Recall, followed by the Food Record. The overall relative validity of the FFQ to estimate energy, macronutrient, certain micronutrient, and certain food item intakes in children and adolescents may be considered weak. The study protocol was registered in PROSPERO under number CRD42016038706.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The relative age effect on physical fitness in preschool children

  • Cupeiro, R.
  • Rojo-Tirado, M.A.
  • Cadenas-Sanchez, C.
  • Artero, E.G.
  • Peinado, A.B.
  • Labayen, I.
  • Dorado, C.
  • Arias-Palencia, N.M.
  • Moliner-Urdiales, D.
  • Vidal-Conti, J.
  • Conde-Caveda, J.
  • Mora-Gonzalez, J.
  • Vicente-Rodríguez, G.
  • Benito, P.J.
The aim of the present study was to investigate the existence of a relative age effect (RAE) on physical fitness of preschoolers. Anthropometry and physical fitness were assessed in 3147 children (3–5 years old) using the PREFIT battery. Based on the birth year, participants were divided into 3year groups (3-, 4- and 5-years). Within each year group, 4quarter groups were created: quarter 1, preschoolers born from January to March; quarter 2, from April to June; quarter 3, from July to September; quarter 4, from October to December. The MANCOVA analysis revealed a main effect of year group (Wilks’ ¿ = 0.383; F10, 5996 = 369.64; p < 0.001, ¿p 2 = 0.381) and of quarter (Wilks’ ¿ = 0.874; F15, 8276.6 = 27.67; p < 0.001; ¿p 2 = 0.044) over the whole battery of tests. To the best of our knowledge, this is the first study to report the existence of RAE at the preschool stage. In general, performance improved as the relative age increased (i.e., those born in quarter 1 performed better than those in the other quarters). Individualization strategies should be addressed within the same academic year not only in elementary or secondary years but also in preschoolers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Association Between Physical Fitness and Bone Strength and Structure in 3- to 5-Year-Old Children

  • Gómez-Bruton, A.
  • Marín-Puyalto, J.
  • Muñiz-Pardos, B.
  • Lozano-Berges, G.
  • Cadenas-Sanchez, C.
  • Matute-Llorente, A.
  • Gómez-Cabello, A.
  • Moreno, L.A.
  • Gonzalez-Agüero, A.
  • Casajus, J.A.
  • Vicente-Rodríguez, G.
Background: The positive association between physical fitness and bone structure has been widely investigated in children and adolescents, yet no studies have evaluated this influence in young children (ie, preschoolers). Hypothesis: Fit children will present improved bone variables when compared with unfit children, and no sex-based differences will emerge in the sample. Study Design: Cross-sectional study. Level of Evidence: Level 3. Methods: Handgrip strength, standing long jump (SLJ), speed/agility, balance, and cardiorespiratory fitness (CRF) were assessed using the Assessing FITness levels in PREschoolers (PREFIT) test battery in 92 children (50 boys; age range, 3-5 years). A peripheral quantitative computed tomography scan was performed at 38% of the length of the nondominant tibia. Cluster analysis from handgrip strength, SLJ, speed/agility, and CRF was developed to identify fitness groups. Bone variables were compared between sexes and between cluster groups. The association between individual physical fitness components and different bone variables was also tested. Results: Three cluster groups emerged: fit (high values on all included physical fitness variables), strong (high strength values and low speed/agility and CRF), and unfit (low strength, speed/agility, and CRF). The fit group presented higher values than the strong and unfit groups for total and cortical bone mineral content, cortical area, and polar strength strain index (all P < 0.05). The fit group also presented a higher cortical thickness when compared with the unfit group (P < 0.05). Handgrip, SLJ, and speed/agility predicted all bone variables except for total and cortical volumetric bone mineral density. No differences were found for bone variables between sexes. Conclusion: The results suggest that global fitness in preschoolers is a key determinant for bone structure and strength but not volumetric bone mineral density. Clinical Relevance: Physical fitness is a determinant for tibial bone mineral content, structure, and strength in very young children. Performing physical fitness tests could provide useful information related to bone health in preschoolers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Trends in Outcomes for Neonates Born Very Preterm and Very Low Birth Weight in 11 High-Income Countries

  • Lui, K.
  • Lee, S.K.
  • Kusuda, S.
  • Adams, M.
  • Vento, M.
  • Reichman, B.
  • Darlow, B.A.
  • Lehtonen, L.
  • Modi, N.
  • Norman, M.
  • Hakansson, S.
  • Bassler, D.
  • Rusconi, F.
  • Lodha, A.
  • Yang, J.M.
  • Shah, P.S.
  • Marshall, P.
  • Schmidt, P.
  • Dhawan, A.
  • Craven, P.
  • de Waal, K.
  • Simmer, K.
  • Gill, A.
  • Pillow, J.
  • Stack, J.
  • Birch, P.
  • Cooke, L.
  • Casalaz, D.
  • Holberton, J.
  • Stewart, A.
  • Downe, L.
  • Stewart, M.
  • Bajuk, B.
  • Berry, A.
  • Hunt, R.
  • Kilburn, C.
  • De Paoli, T.
  • Bolisetty, S.
  • Paradisis, M.
  • Rieger, I.
  • Koorts, P.
  • Kuschel, C.
  • Doyle, L.
  • Numa, A.
  • Carlisle, H.
  • Badawi, N.
  • Loughran-Fowlds, A.
  • Koh, G.
  • Davis, J.
  • Luig, M.
  • Andersen, C.
  • Chambers, G.
  • Austin, N.
  • Lynn, A.
  • Darlow, B.
  • Edmonds, L.
  • Mildenhall, L.
  • Buksh, M.
  • Battin, M.
  • van den Boom, J.
  • Bourchier, D.
  • Richardson, V.
  • Dineen, F.
  • Rajadurai, V.S.
  • Lam, S.
  • Fung, G.
  • Harrison, A.
  • Synnes, A.
  • Cieslak, Z.
  • Sherlock, R.
  • Yee, W.
  • Aziz, K.
  • Fajardo, C.
  • Kalapesi, Z.
  • Sankaran, K.
  • Daspal, S.
  • Seshia, M.
  • Alvaro, R.
  • Mukerji, A.
  • Da Silva, O.
  • Nwaesei, C.
  • Lee, K.S.
  • Dunn, M.
  • Lemyre, B.
  • Dow, K.
  • Pelausa, E.
  • Barrington, K.
  • Drolet, C.
  • Piedboeuf, B.
  • Claveau, M.
  • Beltempo, M.
  • Bertelle, V.
  • Masse, E.
  • Canning, R.
  • Makary, H.
  • Ojah, C.
  • Monterrosa, L.
  • Deshpandey, A.
  • Afifi, J.
  • Kajetanowicz, A.
  • Andersson, S.
  • Tammela, O.
  • Sankilampi, U.
  • Saarela, T.
  • Prazad, P.
  • Noguchi, A.
  • McWan, K.
  • Button, B.
  • Stratton, W.
  • Hamvus, A.
  • Raghaven, A.
  • Derrick, M.
  • Hadley, R.
  • Covert, R.
  • Lablanc, O.
  • Weiss, M.
  • Bell, A.
  • Shareef, M.
  • Silvestri, J.
  • Heymann, E.
  • Zangen, S.
  • Smolkin, T.
  • Mimouni, F.
  • Bader, D.
  • Rothschild, A.
  • Strauss, Z.
  • Felszer, C.
  • Omari, H.
  • Tov-Friedman, S.E.
  • Bar-Oz, B.
  • Feldman, M.
  • Saad, N.
  • Flidel-Rimon, O.
  • Weisbrod, M.
  • Lubin, D.
  • Litmanovitz, I.
  • Kugelman, A.
  • Shinwell, E.
  • Klinger, G.
  • Nijim, Y.
  • Bin-Nun, A.
  • Golan, A.
  • Mandel, D.
  • Fleisher-Sheffer, V.
  • Kohelet, D.
  • Bakhrakh, L.
  • Hattori, S.
  • Shirai, M.
  • Ishioka, T.
  • Mori, T.
  • Amizuka, T.
  • Huchimukai, T.
  • Rite Gracia, Segundo
  • Ventura Faci, Maria Purificacion
  • Samper Villagrasa, M. Pilar
Objective To evaluate outcome trends of neonates born very preterm in 11 high-income countries participating in the International Network for Evaluating Outcomes of neonates. Study design In a retrospective cohort study, we included 154 233 neonates admitted to 529 neonatal units between January 1, 2007, and December 31, 2015, at 24(0/7) to 31(6/7) weeks of gestational age and birth weight <1500 g. Composite outcomes were in-hospital mortality or any of severe neurologic injury, treated retinopathy of prematurity, and bronchopulmonary dysplasia (BPD); and same composite outcome excluding BPD. Secondary outcomes were mortality and individual morbidities. For each country, annual outcome trends and adjusted relative risks comparing epoch 2 (2012-2015) to epoch 1 (2007-2011) were analyzed. Results For composite outcome including BPD, the trend decreased in Canada and Israel but increased in Australia and New Zealand, Japan, Spain, Sweden, and the United Kingdom. For composite outcome excluding BPD, the trend decreased in all countries except Spain, Sweden, Tuscany, and the United Kingdom. The risk of composite outcome was lower in epoch 2 than epoch 1 in Canada (adjusted relative risks 0.78; 95% CI 0.74-0.82) only. The risk of composite outcome excluding BPD was significantly lower in epoch 2 compared with epoch 1 in Australia and New Zealand, Canada, Finland, Japan, and Switzerland. Mortality rates reduced in most countries in epoch 2. BPD rates increased significantly in all countries except Canada, Israel, Finland, and Tuscany. Conclusions In most countries, mortality decreased whereas BPD increased for neonates born very preterm.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Contribución de congreso (ConferenceOutput)

Fluid intake habits of spanish children and adolescents: an update of the Liq.In7 survey

  • Iglesia-Altaba, Iris
  • Miguel-Berges, Maria Luisa
  • Morin, Clementine
  • Moreno-Aznar, Luis A.
Insufficient and unhealthy total fluid intake (TFI), especially in early stages of life, may have negative health impact [1]. Understanding how fluid consumption may differ throughout the day or as a function of location could help drive policy initiatives to encourage healthier drinking habits, especially in young population groups, so this study assesses current patterns of fluid consumption in children and adolescents in Spain, including drinking occasions and locations and to compare TFI with the adequate intake of water from fluids recommended by the European Food Safety Authority (EFSA)...
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Associations between Spanish children’s physical activity and physical fitness with lean body mass: The CALINA study

  • Córdoba Rodríguez, D.P.
  • Iglesia, I.
  • Gómez Bruton, A.
  • Miguel Berges, M.L.
  • Flores Barrantes, P.
  • Casajús Mallén, J.A.
  • Moreno, L.A.
  • Rodríguez, G.
The present study investigated the associations between physical activity (PA) and physical fitness (PF) with lean body mass (LBM) and evaluated whether PA mediates the association between PF and LBM. 279 children (150 boys) aged 7.5 ± 0.3 years participated in the study. PA was assessed by accelerometry and PF with handgrip and the standing long jump test. Total lean soft tissue mass index (TLSTMI), muscle cross-sectional area index (MCSAI), and fat-free mass index (FFMI) were evaluated using dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and bioimpedance analysis, respectively. Total (β = 0.247) and vigorous PA (β = 0.143) were associated with TLSTMI in girls. In boys, total (β = 0.337), light (β = 0.290), vigorous (β = 0.200), and moderate-vigorous PA (β = 0.189) were associated with TLSTMI. Total PA was associated with FFMI (β = 0.299). Handgrip strength does not mediate the relationship between total PA and TLSTMI. Positive associations were found between handgrip strength and TLSTMI, MCSAI, and FFMI in both girls and boys. In children, there is a positive association between total and vigorous PA with TLSTMI. Handgrip strength does not mediate the relationship between total PA and TLSTMI. It was associated with TLSTMI, MCSAI, and FFMI.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Early Nutrition and Later Excess Adiposity during Childhood: A Narrative Review

  • Iglesia Altaba, Iris
  • Larqué, Elvira
  • Mesa, María Dolores
  • Blanco-Carnero, José Eliseo
  • Gomez-Llorente, Carolina
  • Rodríguez-Martínez, Gerardo
  • Moreno, Luis A.
Background: Studies on childhood obesity mainly focus on the genetic component and on the lifestyle that may be associated with the development of obesity. However, the study of perinatal factors in their programming effect toward future obesity in children or adults is somewhat more recent, and there are still mechanisms to be disentangled. Summary: In this narrative review, a comprehensive route based on the influence of some early factors in life in the contribution to later obesity development is presented. Maternal pre-pregnancy BMI and gestational weight gain have been pointed out as independent determinants of infant later adiposity. Lifestyle interventions could have an impact on pregnant mothers through epigenetic mechanisms capable of redirecting the genetic expression of their children toward a future healthy weight and body composition and dietary-related microbiome modifications in mothers and newborns might also be related. After birth, infant feeding during the first months of life is directly associated with its body composition and nutritional status. From this point of view, all the expert committees in the world are committed to promote exclusive breastfeeding up to 6 months of age and to continue at least until the first year of life together with complementary feeding based on healthy dietary patterns such as Mediterranean Diet.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review

  • Gomez-Roig, MD
  • Pascal, R
  • Cahuana, MJ
  • Garcia-Algar, O
  • Sebastiani, G
  • Andreu-Fernandez, V
  • Martinez, L
  • Rodriguez, G
  • Iglesia, I
  • Ortiz-Arrabal, O
  • Mesa, MD
  • Cabero, MJ
  • Guerra, L
  • Llurba, E
  • Dominguez, C
  • Zanini, MJ
  • Foraster, M
  • Larque, E
  • Cabanas, F
  • Lopez-Azorin, M
  • Perez, A
  • Loureiro, B
  • Pallas-Alonso, CR
  • Escuder-Vieco, D
  • Vento, M
Preconception and prenatal exposure to environmental contaminants may affect future health. Pregnancy and early life are critical sensitive windows of susceptibility. The aim of this review was to summarize current evidence on the toxic effects of environment exposure during pregnancy, the neonatal period, and childhood. Alcohol use is related to foetal alcohol spectrum disorders, foetal alcohol syndrome being its most extreme form. Smoking is associated with placental abnormalities, preterm birth, stillbirth, or impaired growth and development, as well as with intellectual impairment, obesity, and cardiovascular diseases later in life. Negative birth outcomes have been linked to the use of drugs of abuse. Pregnant and lactating women are exposed to endocrine-disrupting chemicals and heavy metals present in foodstuffs, which may alter hormones in the body. Prenatal exposure to these compounds has been associated with pre-eclampsia and intrauterine growth restriction, preterm birth, and thyroid function. Metals can accumulate in the placenta, causing foetal growth restriction. Evidence on the effects of air pollutants on pregnancy is constantly growing, for example, preterm birth, foetal growth restriction, increased uterine vascular resistance, impaired placental vascularization, increased gestational diabetes, and reduced telomere length. The advantages of breastfeeding outweigh any risks from contaminants. However, it is important to assess health outcomes of toxic exposures via breastfeeding. Initial studies suggest an association between pre-eclampsia and environmental noise, particularly with early-onset pre-eclampsia. There is rising evidence of the negative effects of environmental contaminants following exposure during pregnancy and breastfeeding, which should be considered a major public health issue.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Are spanish children drinking enough and healthily? An update of the liq.in7 cross-sectional survey in children and adolescents [¿Beben los niños y adolescentes españoles lo suficiente y de forma saludable? Actualización del estudio transversal Liq.in7 en niños y adolescentes]

  • Iglesia-Altaba I.
  • Miguel-Berges M.L.
  • Morin C.
  • Moreno-Aznar L.A.
Introduction: Insufficient and/or unhealthy total fluid intake (TFI), especially in the early stages of life, may have a negative impact on health. Objective: To assess the current patterns of fluid consumption in children and adolescents in Spain, including drinking occasions and locations (e.g., at home or at school), and to compare TFI with adequate intake (AI) of water from fluids as recommended by the European Food Safety Agency (EFSA). Methodology: A Spanish cross-sectional study was performed assessing TFI from all sources of fluid consumption according to drinking occasions during the day and location, using a validated liquid intake 7-day record (Liq.in7). Data collection occurred between April and May, 2018. A sample of 146 (63% boys) children (4-9 years old) and adolescents (10-17 years old) was included. Parents reported such information when children were under 16 years. Results: A high proportion of children and adolescents did not meet EFSA-derived reference values for fluid intake (73% and 72%, respectively). Forty percent of children and about 50% of adolescents consumed at least one serving of sugar-sweetened beverage (SSB) per day, while about 20% consumed only one or less servings of water per day. Consumption during the main meals was most important for both children and adolescents (representing 50% and 54% of TFI, respectively), and was mainly driven by water (62%). Consumption at home in children (70% of TFI) was made of water (47%). In the same way, at school, water contributed to half intake. However, adolescent girls at school drink more SSBs (41%) than water (34%), the former being the most consumed fluid. At other locations, adolescent boys also drink more SSBs (51%) than either water (29%) or milk and derivatives (10%). Conclusion: The drinking habits of Spanish young populations are far removed from current recommendations because of a low fluid intake, specifically water, and a high proportion of SSB consumption in children and adolescents. Interventions to ensure that EFSA TFI recommendations are met are of special importance for children and adolescents, with-according to our results-a special focus on male adolescents. © 2021 SENPE Arán Ediciones S.L.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Early Life Factors Associated with Lean Body Mass in Spanish Children: CALINA Study

  • Córdoba-Rodríguez, Diana Paola
  • Iglesia, Iris
  • Gómez-Bruton, Alejandro
  • Álvarez Sauras, María Luisa
  • Miguel-Berges, María L.
  • Flores-Barrantes, Paloma
  • Casajús, José Antonio
  • Moreno, Luis A.
  • Rodríguez, Gerardo
Early life is critical for the programming of body composition. The literature links perinatal factors with fat mass development and its future effects (e.g., obesity); however, little evidence exists between early life factors and lean body mass (LBM). This study follows up on a cohort of 416 Spanish children at ages six to eight, previously evaluated at birth in the CALINA study. Here, we studied the association between early life factors, LBM, and limb strength. Parental origin/nutritional status, maternal smoking during pregnancy, gestational diabetes/weight gain/age, birth weight (BW), early feeding, and rapid weight gain (RWG) were collected from primary care records. Bioimpedance analysis, dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and a handgrip/standing long jump test were used to assess fat-free mass index (FFMI), total lean soft tissue mass index (TLSTMI), muscle cross-sectional area index (MCSAI), and limb strength, respectively. In girls, maternal smoking, gestational age, and BW were positively associated with FFM/LSTM. In boys, the parents’ BMI, BW, and RWG were positively associated with FFM/LSTM. BW was associated with handgrip strength in both. Maternal BMI in girls and RWG in boys were negatively associated with the standing long jump. Early life programming plays a key role in determining LBM in children. © MDPI. All rights reserved.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

  • Sanchez García, Olga
  • Martínez, Sandra
  • Dominguez Luengo, Mari Carmen
  • Ruiz Pace, Fiorella
  • Céspedes Domínguez, María Concepción
  • Peñuelas Saiz, Angeles
  • Cortés Castan, Javier
  • Saura Manich, Cristina
  • Dienstmann, Rodrigo
Factors angiogènics; Quimioteràpia; Embaràs, Factores angiogénicos; Quimioterapia; Embarazo, Angiogenic factors; Chemotherapy; Pregnancy, High prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic factors, surrogate markers for placental insufficiency, that could explain perinatal outcomes. Methods: Prospective study between 2012 and 2016 in a single institution. Soluble fms-like tyrosine kinase (sFlt-1), placental growth factor (PlGF), and soluble endoglin (sEng) in maternal blood were assessed throughout pregnancy in 12 women with BC and 215 controls. Results: Cancer patients were treated with doxorubicin-based regimes and with taxanes. Ten PBC-CHT (83%) developed obstetrical complications. At the end of the third trimester, significantly higher levels of sFlt-1; sFlt-1/PGF ratio, and sEng levels were observed in BC women as compared to controls. Moreover; there was a significant correlation between plasma levels of sFlt-1 and the number of chemotherapy cycles administered. Besides, more chemotherapy cycles correlated with lower birthweight and head circumference at birth. Conclusions: Women with BC treated during pregnancy showed an antiangiogenic state compatible with placental insufficiency. Angiogenic factors could be useful in the clinical obstetric management of these patients; although further studies will be required to guide clinical decision-making., This study was funded by the Spanish Research Project in Health funded by ISCIII, the state plan for scientific and technical research and innovation 2015–2018, and European Regional Development Fund (ERDF), ref. PI15/02252. This study was also supported in part by RETICS ‘Maternal and Child Health and Development Network’ (SAMID Network), funded by the PN I + D + i 2008–2016 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion, and the European Regional Development Fund (ERDF), ref. RD12/0026 and RD16/0022. O.S. was supported by SAMID Network (RD12/0026/0016 and RD16/0022/0015) and S.M. was supported by “Paseico de la mama”.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers

  • Cruz-Lemini, Mónica
  • Álvarez, Francisco V.
  • Nan, Madalina Nicoleta
  • Carretero, Francisco
  • Fernández-Oliva, Antonio
  • Alijotas Reig, Jaume
  • Garrido-Giménez, Carmen
Angiogenic factors; Preeclampsia; Uric acid, Factores angiogénicos; Preeclampsia; Ácido úrico, Factors angiogènics; Preeclàmpsia; Àcid úric, N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24+0 and 36+6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5-88.2) compared to 72.8% (95% CI 67.4-78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926-0.956) vs. 0.901 (95% CI 0.880-0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937-0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890-0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision., This work was supported by public funds obtained in competitive calls with peer review (grant PI19/00702), Insituto de Salud Carlos III, Spanish Ministry of Health, by the Maternal and Child Health and Development Network (SAMID, RD16/0022/0015), Instituto de Salud Carlos III, Madrid, Spain, the Spanish Clinical Research and Clinical Trials Platform, SCReN (Spanish Clinical Research Network), funded by the ISCIII-General Subdirectorate for Evaluation and Promotion of Research, through project PT13/0002/0028, integrated in the 2013–2016 R + D + I State Plan and co-financed by and the European Regional Development Fund (FEDER); and by the Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin Network (RICORS, RD21/0012/0001), Instituto de Salud Carlos III, Madrid, Spain, funded by the Recovery, Transformation and Resilience Plan 2017–2020, ISCIII, and by the European Union-Next Generation EU. Dr Cruz-Lemini is supported by Juan Rodés contract JR19/00047, Instituto de Salud Carlos III-Spanish Ministry of Health. Funding sources were not involved in study design, collection, analysis, and interpretation of data.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART), study protocol

  • Ribera, Irene
  • Ruiz, Aina
  • Sánchez Martínez, M. Olga|||0000-0003-1254-012X
  • Eixarch, Elisenda|||0000-0001-7379-9608
  • Antolin, Eugenia
  • Gómez-Montes, E.
  • Pérez-Cruz, M.
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Sanz-Cortés, M.
  • Arévalo, Silvia|||0000-0001-8169-1322
  • Ferrer Menduiña, Queralt|||0000-0003-3177-4618
  • Vázquez Méndez, Elida
  • Vega, L.
  • Dolader, Paola|||0000-0003-3497-4201
  • Montoliu, A.
  • Boix, Hector|||0000-0002-8613-1401
  • Simões, R. V.
  • Masoller, N.
  • Sánchez de Toledo, Joan|||0000-0002-9108-4750
  • Comas, M.
  • Bartha, J. M.
  • Galindo Izquierdo, Alberto
  • Martínez Crespo, Josep Maria
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Crispi, Fatima|||0000-0002-7422-5240
  • Gómez, Olga|||0000-0003-4183-9876
  • Carreras Moratonas, Elena|||0000-0003-3471-7248
  • Cabero i Roura, Lluís|||0000-0002-1905-5680
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Llurba, Elisa|||0000-0003-4048-6407
Congenital heart disease (CHD) is the most prevalent congenital malformation affecting 1 in 100 newborns. While advances in early diagnosis and postnatal management have increased survival in CHD children, worrying long-term outcomes, particularly neurodevelopmental disability, have emerged as a key prognostic factor in the counseling of these pregnancies. Eligible participants are women presenting at 20 to < 37 weeks of gestation carrying a fetus with CHD. Maternal/neonatal recordings are performed at regular intervals, from the fetal period to 24 months of age, and include: placental and fetal hemodynamics, fetal brain magnetic resonance imaging (MRI), functional echocardiography, cerebral oxymetry, electroencephalography and serum neurological and cardiac biomarkers. Neurodevelopmental assessment is planned at 12 months of age using the ages and stages questionnaire (ASQ) and at 24 months of age with the Bayley-III test. Target recruitment is at least 150 cases classified in three groups according to three main severe CHD groups: transposition of great arteries (TGA), Tetralogy of Fallot (TOF) and Left Ventricular Outflow Tract Obstruction (LVOTO). The results of NEURO-HEART study will provide the most comprehensive knowledge until date of children's neurologic prognosis in CHD and will have the potential for developing future clinical decisive tools and improving preventive strategies in CHD. , on 4th December 2016 (retrospectively registered).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Bioavailability of epigallocatechin gallate administered with different nutritional strategies in healthy volunteers

  • Andreu-Fernandez, Vicente|||0000-0001-7183-8706
  • Toledano, L. A.
  • Pizarro Lozano, Nieves|||0000-0003-2671-7184
  • Tapia, E. N.
  • Roig, M. D. G.
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Algar, Ó. G.
The flavanol epigallocatechin gallate (EGCG) is being tested for the treatment of several diseases in humans. However, its bioavailability and pharmacokinetic profile needs a better understanding to enable its use in clinical trials. There is no consensus on the most appropriate concentration of EGCG in the body to obtain the maximum therapeutic effects. Therefore, the aim of this study is to analyze the bioavailability of EGCG orally administered alone or with different food supplements after overnight fasting in order to determine its optimal conditions (high concentrations in blood and the lowest interindividual variations) to be used as a pharmacological tool in human trials. Ten healthy volunteers (5 men and 5 women) aged 25 to 35 years were recruited prospectively. Three series of clinical experiments with a washout period of seven days among each were performed: 1) Teavigo® (EGCG extract) alone, 2) Teavigo® with a standard breakfast, and 3) FontUp® (Teavigo® commercially prepared with fats, carbohydrates, proteins, vitamins, and minerals). Blood samples were collected at 0, 30, 60, 90, 120, 180, 240, and 360 min after EGCG intake. Free EGCG in plasma was measured using a liquid chromatography and mass spectrometry UPLC-ESI-MS/MS analytical method. The pharmacokinetic variables analyzed statistically were area under the curve (AUC0-360), Cmax, Cav, Cmin, T1/2, and Tmax,. EGCG (Teavigo®) alone was the group with higher AUC0-360, Cmax, and Cav both in men (3.86 ± 4.11 μg/mL/kg/6 h; 5.95 ng/mL/kg; 2.96 ng/mL/kg) and women (3.33 ± 1.08 μg/mL/kg/6 h; 6.66 ng/mL/kg; 3.66 ng/mL). Moreover, FontUp® was the group with the highest value of T1/2 both in men (192 ± 66 min) and women (133 ± 28 min). Teavigo® intake after fasting overnight revealed the highest concentration of EGCG in plasma according to its pharmacokinetic profile, indicating that this is an excellent alternative of administration if the experimental design requires good absorption in the gastrointestinal tract. Moreover, EGCG taken along with food supplements (FontUp®) improved the stability of the molecule in the body, being the best choice if the experimental design wants to reduce interindividual variation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prevalence of Fetal Alcohol Spectrum Disorders (FASD) among Children Adopted from Eastern European Countries, Russia and Ukraine

  • Colom Farran, J.|||0000-0001-6861-7865
  • Segura-García, Lidia
  • Bastons-Compta, Adriana
  • Astals, Marta
  • Andreu-Fernandez, Vicente|||0000-0001-7183-8706
  • Barcons i Castel, Natàlia
  • Vidal, Raquel
  • Ibar, Ana I.
  • Fumadó, Victoria
  • Gomez-Barros, Núria|||0000-0002-7776-6579
  • Russiñol, Agnés
  • Garcia-Algar, Oscar|||0000-0001-5708-4362
Fetal alcohol spectrum disorder (FASD) is a leading cause of neurodevelopmental disorders. Children adopted internationally from countries where alcohol consumption during pregnancy is very high are at greater risk for FASD. Lack of expertise in diagnosing FASD and mixed neurodevelopmental and behavioral signs due to abandonment complicate a timely diagnosis. The aim of this study was to determine the prevalence of FASD in adopted children. Children between the ages of 8 and 24 adopted from Russia and Ukraine were evaluated for clinical and historical features of FASD. Of the 162 children evaluated, 81 (50%) met FASD diagnostic criteria. Thirty-three (20.4%) children had fetal alcohol syndrome (FAS), 28 (17.2%) had partial FAS, 2 (1.2%) had alcohol-related birth defects (ARBD) and 18 (11.1%) had alcohol-related neurodevelopmental disorder (ARND). Of the 81 children in which fetal alcohol exposure could not be confirmed, many had manifestations that would have established a diagnosis of FASD if a history of maternal alcohol consumption was confirmed. In a population of children with a high risk of prenatal alcohol exposure (adoptees from Eastern European countries), at least 50% showed manifestations associated with FASD. The reported prevalence in this study is in line with the results obtained in a previous study as well as in orphanages of origin.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Evolving Microbiome from Pregnancy to Early Infancy, A Comprehensive Review

  • Mesa, María Dolores|||0000-0003-4079-6464
  • Loureiro, Begoña|||0000-0001-6065-1364
  • Iglesia, Iris|||0000-0002-2219-3646
  • Fernandez Gonzalez, Sergi
  • Llurba, Elisa|||0000-0003-4048-6407
  • Garcia-Algar, Oscar|||0000-0001-5708-4362
  • Solana, María José|||0000-0001-6083-2528
  • Cabero Perez, Mª Jesús
  • Sainz, Talia|||0000-0002-5301-0945
  • Martinez, Leopoldo
  • Escuder-Vieco, Diana
  • Parra-Llorca, Anna
  • Sánchez-Campillo, María|||0000-0002-7177-8341
  • Rodriguez Martinez, Gerardo
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Perez Gruz, Myriam
  • Andreu-Fernandez, Vicente|||0000-0001-7183-8706
  • Clotet, Jordi
  • Sailer, Sebastian
  • Iglesias-Platas, Isabel
  • López Herce, Jesús|||0000-0001-6105-9178
  • Aras, Rosa
  • Pallás-Alonso, Carmen|||0000-0001-9710-8162
  • Saenz de Pipaon, Miguel|||0000-0002-4793-1561
  • Vento Torres, Máximo|||0000-0003-0061-4742
  • Gormaz, María
  • Larqué Daza, Elvira
  • Calvo, Cristina|||0000-0002-6503-3423
  • Cabañas, Fernando
Pregnancy induces a number of immunological, hormonal, and metabolic changes that are necessary for the mother to adapt her body to this new physiological situation. The microbiome of the mother, the placenta and the fetus influence the fetus growth and undoubtedly plays a major role in the adequate development of the newborn infant. Hence, the microbiome modulates the inflammatory mechanisms related to physiological and pathological processes that are involved in the perinatal progress through different mechanisms. The present review summarizes the actual knowledge related to physiological changes in the microbiota occurring in the mother, the fetus, and the child, both during neonatal period and beyond. In addition, we approach some specific pathological situations during the perinatal periods, as well as the influence of the type of delivery and feeding. his research was funded by the PN I+D+I 2008-2011 (Spain), ISCIII- Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), RETICS Maternal and Child Health and Development Network, SAMID Network, Ref.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

  • Saura Manich, Cristina|||0000-0001-8296-5065
  • Sánchez Martínez, M. Olga|||0000-0003-1254-012X
  • Martínez, Sandra
  • Domínguez Luengo, Carmen|||0000-0003-4684-1887
  • Dienstmann, Rodrigo|||0000-0001-5997-318X
  • Ruíz-Pace, Fiorella|||0000-0002-3932-0170
  • Céspedes, Maria Concepció
  • Peñuelas, Ángeles
  • Cortés Castán, Javier|||0000-0001-7623-1583
  • Llurba, Elisa|||0000-0003-4048-6407
  • Cordoba Cardona, Octavi|||0000-0002-9591-7430
Anthracyclines and taxanes are being used as a standard treatment for breast cancer diagnosed during pregnancy. These chemotherapy regimens allow the continuation of pregnancy without delaying cancer treatment with relatively good maternal and neonatal outcomes. However, their effects on placental function and fetal development are not completely understood. Maternal serum angiogenic factors are a surrogate of placental function and are abnormal weeks before placental complications such as preeclampsia or intrauterine growth restriction development. In our cohort, pregnant women with breast cancer treated with chemotherapy during pregnancy show an antiangiogenic state with significantly higher levels of soluble fms-like tyrosine kinase (sFlt-1), sFlt-1/PGF ratio, and soluble endoglin (sEng) at the end of the third trimester. Angiogenic factors could be useful in the clinical obstetric management of these patients, although more studies are guaranteed. High prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic factors, surrogate markers for placental insufficiency, that could explain perinatal outcomes. Methods: Prospective study between 2012 and 2016 in a single institution. Soluble fms-like tyrosine kinase (sFlt-1), placental growth factor (PlGF), and soluble endoglin (sEng) in maternal blood were assessed throughout pregnancy in 12 women with BC and 215 controls. Results: Cancer patients were treated with doxorubicin-based regimes and with taxanes. Ten PBC-CHT (83%) developed obstetrical complications. At the end of the third trimester, significantly higher levels of sFlt-1; sFlt-1/PGF ratio, and sEng levels were observed in BC women as compared to controls. Moreover; there was a significant correlation between plasma levels of sFlt-1 and the number of chemotherapy cycles administered. Besides, more chemotherapy cycles correlated with lower birthweight and head circumference at birth. Conclusions: Women with BC treated during pregnancy showed an antiangiogenic state compatible with placental insufficiency. Angiogenic factors could be useful in the clinical obstetric management of these patients; although further studies will be required to guide clinical decision-making.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia, the ANGIOCOR prospective cohort study protocol

  • Ullmo, Johana|||0000-0002-9313-917X
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Bos-Real, L.|||0000-0002-6159-0644
  • Fernandez-Llama, Patricia|||0000-0002-7472-2124
  • Calero, Francesca|||0000-0002-5758-0769
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Trilla, Cristina|||0000-0002-5650-1790
  • Carreras Costa, Francesc|||0000-0002-1944-0562
  • Sionis, Alessandro|||0000-0003-0843-9512
  • Mora, J.
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Cardiovascular diseases (CVD) are cause of increased morbidity and mortality in spite of advances for diagnosis and treatment. Changes during pregnancy affect importantly the maternal CV system. Pregnant women that develop preeclampsia (PE) have higher risk (up to 4 times) of clinical CVD in the short- and long-term. Predominance of an anti-angiogenic environment during pregnancy is known as main cause of PE, but its relationship with CV complications is still under research. We hypothesize that angiogenic factors are associated to maternal cardiac dysfunction/remodeling and that these may be detected by new cardiac biomarkers and maternal echocardiography. Methods: Prospective cohort study of pregnant women with high-risk of PE in first trimester screening, established diagnosis of PE during gestation, and healthy pregnant women (total intended sample size n = 440). Placental biochemical and biophysical cardiovascular markers will be assessed in the first and third trimesters of pregnancy, along with maternal echocardiographic parameters. Fetal cardiac function at third trimester of pregnancy will be also evaluated and correlated with maternal variables. Maternal cardiac function assessment will be determined 12 months after delivery, and correlation with CV and PE risk variables obtained during pregnancy will be evaluated. Discussion: The study will contribute to characterize the relationship between anti-angiogenic environment and maternal CV dysfunction/remodeling, during and after pregnancy, as well as its impact on future CVD risk in patients with PE. The ultimate goal is to improve CV health of women with high-risk or previous PE, and thus, reduce the burden of the disease. Trial registration: NCT04162236.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers

  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Álvarez Menéndez, Francisco V.|||0000-0002-2553-5402
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Carretero, Francisco
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Sánchez García, Olga|||0000-0002-5279-440X
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Alijotas-Reig, Jaume|||0000-0002-9212-3619
  • Llurba, Elisa|||0000-0003-4048-6407
N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24 +0 and 36 +6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5-88.2) compared to 72.8% (95% CI 67.4-78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926-0.956) vs. 0.901 (95% CI 0.880-0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937-0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890-0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal Behavior of Left-Ventricular Strain in Fetal Growth Restriction

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) is associated with an increased risk of adverse outcomes resulting from adaptive cardiovascular changes in conditions of placental insufficiency, leading to cardiac deformation and dysfunction, which can be evaluated with 2D speckle tracking echocardiography (2D-STE). The aim of the present study was to evaluate whether reduced fetal growth is associated with cardiac left-ventricle (LV) dysfunction, using 2D-STE software widely used in postnatal echocardiography. A prospective longitudinal cohort study was performed, and global (GLO) and segmental LV longitudinal strain was measured offline and compared between FGR and appropriate-for-gestational-age (AGA) fetuses throughout gestation. All cases of FGR fetuses were paired 1:2 to AGA fetuses, and linear mixed model analysis was performed to compare behavior differences between groups throughout pregnancy. Our study shows LV fetal longitudinal strain in FGR and AGA fetuses differed upon diagnosis and behaved differently throughout gestation. FGR fetuses had lower LV strain values, both global and segmental, in comparison to AGA, suggesting subclinical cardiac dysfunction. Our study provides more data regarding fetal cardiac function in cases of placental dysfunction, as well as highlights the potential use of 2D-STE in the follow-up of cardiac function in these fetuses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cord Blood Cardiovascular Biomarkers in Left-Sided Congenital Heart Disease

  • Soveral, Iris|||0000-0002-3571-1780
  • Guirado, Laura
  • Escobar-Diaz, Maria C.|||0000-0001-9875-3593
  • Alcaide, María José|||0000-0003-3472-8107
  • Martínez Crespo, Josep Maria
  • Rodríguez Sureda, Víctor|||0000-0003-4942-9249
  • Bijnens, Bart
  • Antolin, Eugenia
  • Llurba, Elisa|||0000-0003-4048-6407
  • Bartha, José Luis
  • Gómez, Olga|||0000-0003-4183-9876
  • Crispi, Fatima|||0000-0002-7422-5240
Fetal echocardiography has limited prognostic ability in the evaluation of left-sided congenital heart defects (left heart defects). Cord blood cardiovascular biomarkers could improve the prognostic evaluation of left heart defects. A multicenter prospective cohort (2013-2019) including fetuses with left heart defects (aortic coarctation, aortic stenosis, hypoplastic left heart, and multilevel obstruction (complex left heart defects) subdivided according to their outcome (favorable vs. poor), and control fetuses were evaluated in the third trimester of pregnancy at three referral centers in Spain. Poor outcome was defined as univentricular palliation, heart transplant, or death. Cord blood concentrations of N-terminal precursor of B-type natriuretic peptide, Troponin I, transforming growth factor β, placental growth factor, and soluble fms-like tyrosine kinase-1 were determined. A total of 45 fetuses with left heart defects (29 favorable and 16 poor outcomes) and 35 normal fetuses were included, with a median follow-up of 3.1 years (interquartile range 1.4-3.9). Left heart defects with favorable outcome showed markedly increased cord blood transforming growth factor β (normal heart median 15.5 ng/mL (6.8-21.4) vs. favorable outcome 51.7 ng/mL (13.8-73.9) vs. poor outcome 25.1 ng/mL (6.9-39.0), p = 0.001) and decreased placental growth factor concentrations (normal heart 17.9 pg/mL (13.8-23.9) vs. favorable outcome 12.8 pg/mL (11.7-13.6) vs. poor outcome 11.0 pg/mL (8.8-15.4), p < 0.001). Poor outcome left heart defects had higher N-terminal precursor of B-type natriuretic peptide (normal heart 508.0 pg/mL (287.5-776.3) vs. favorable outcome 617.0 pg/mL (389.8-1087.8) vs. poor outcome 1450.0 pg/mL (919.0-1645.0), p = 0.001) and drastically reduced soluble fms-like tyrosine kinase-1 concentrations (normal heart 1929.7 pg/mL (1364.3-2715.8) vs. favorable outcome (1848.3 pg/mL (646.9-2313.6) vs. poor outcome 259.0 pg/mL (182.0-606.0), p < 0.001). Results showed that fetuses with left heart defects present a distinct cord blood biomarker profile according to their outcome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Spanish survey on follow-up programmes for children born very preterm

  • Pallás-Alonso, Carmen|||0000-0001-9710-8162
  • Loureiro, Begoña|||0000-0001-6065-1364
  • De la Cruz Bértolo, Javier
  • García González, Pilar
  • Ginovart, Gemma|||0000-0001-8072-1681
  • Jiménez, Ana
  • Martín, Yolanda
  • Soriano, Javier
  • Torres, María José
  • Vento Torres, Máximo|||0000-0003-0061-4742
Aim: To describe variations in practice between follow-up programmes for very preterm children born at less than 32 weeks' gestation or with very low birth weight of less than 1,500 g. Methods: A survey on follow-up practices was electronically distributed to level II and III units among hospitals of the Spanish National Health Service in 2016. The survey included 70 questions covering issues such as follow-up organisation and resources, routine assessments, relationships with other services and families, information management and training. Results: The response rate was 91.5% (141/154). Among respondents, 70.9% (100/141) reported that they do provide follow-up and 42% do so up to six years of age. Routine neurological and ophthalmological follow-up is not performed in 60% and 37% of hospitals, respectively, and a second hearing assessment is not given in 62%. Just 38% of units have psychologist. In 41% of hospitals, training in follow-up skills is not included in Paediatric Residency training programme. Conclusion: Although Spain has a nationwide health system that provides universal health coverage, we found that follow-up care for children born very preterm/very low birth weight is not equitable. Nearly half of paediatric residents receive no training in follow-up for this high-risk population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fetal Left Ventricle Function Evaluated by Two-Dimensional Speckle-Tracking Echocardiography across Clinical Stages of Severity in Growth-Restricted Fetuses

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) can result in adverse perinatal outcomes due to cardiac dysfunction. This study used 2D speckle-tracking echocardiography to assess left ventricle (LV) longitudinal strain across FGR severity stages. A prospective longitudinal cohort study measured global (GLS) and segmental LV longitudinal strain in FGR fetuses, with evaluations conducted at various time points. FGR was classified into subtypes based on published criteria using fetal weight centile and Doppler parameters. A linear mixed model was employed to analyze repeated measures and compare Z-score measurements between groups throughout gestational age. The study included 40 FGR fetuses and a total of 107 evaluations were performed: 21 from small for gestational age (SGA), 74 from the FGR stage I, and 12 from the FGR stage ≥ II. The results indicate that SGA and stage I FGR fetuses exhibit higher LV GLS than stages ≥ II. Throughout gestation, SGA and FGR stage I fetuses showed similar behavior with consistently better LV GLS values when compared to FGR stages ≥ II. No significant differences were observed in LV GLS strain behavior between SGA and FGR stage I. In conclusion, all FGRs show signs of early cardiac dysfunction, with severe cases demonstrating significantly a lower LV GLS when compared to mild cases, suggesting deterioration of cardiac dysfunction with progression of fetal compromise.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

  • Sanchez García, Olga
  • Martínez, Sandra
  • Dominguez Luengo, Mari Carmen
  • Ruiz-Pace, Fiorella
  • Céspedes Domínguez, María Concepción
  • Peñuelas Saiz, Angeles
  • Cortés Castan, Javier
  • Saura Manich, Cristina
  • Dienstmann, Rodrigo
Factors angiogènics; Quimioteràpia; Embaràs, Factores angiogénicos; Quimioterapia; Embarazo, Angiogenic factors; Chemotherapy; Pregnancy, High prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic factors, surrogate markers for placental insufficiency, that could explain perinatal outcomes. Methods: Prospective study between 2012 and 2016 in a single institution. Soluble fms-like tyrosine kinase (sFlt-1), placental growth factor (PlGF), and soluble endoglin (sEng) in maternal blood were assessed throughout pregnancy in 12 women with BC and 215 controls. Results: Cancer patients were treated with doxorubicin-based regimes and with taxanes. Ten PBC-CHT (83%) developed obstetrical complications. At the end of the third trimester, significantly higher levels of sFlt-1; sFlt-1/PGF ratio, and sEng levels were observed in BC women as compared to controls. Moreover; there was a significant correlation between plasma levels of sFlt-1 and the number of chemotherapy cycles administered. Besides, more chemotherapy cycles correlated with lower birthweight and head circumference at birth. Conclusions: Women with BC treated during pregnancy showed an antiangiogenic state compatible with placental insufficiency. Angiogenic factors could be useful in the clinical obstetric management of these patients; although further studies will be required to guide clinical decision-making., This study was funded by the Spanish Research Project in Health funded by ISCIII, the state plan for scientific and technical research and innovation 2015–2018, and European Regional Development Fund (ERDF), ref. PI15/02252. This study was also supported in part by RETICS ‘Maternal and Child Health and Development Network’ (SAMID Network), funded by the PN I + D + i 2008–2016 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion, and the European Regional Development Fund (ERDF), ref. RD12/0026 and RD16/0022. O.S. was supported by SAMID Network (RD12/0026/0016 and RD16/0022/0015) and S.M. was supported by “Paseico de la mama”.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers

  • Cruz-Lemini, Mónica
  • Álvarez, Francisco V.
  • Nan, Madalina Nicoleta
  • Carretero, Francisco
  • Fernández-Oliva, Antonio
  • Alijotas Reig, Jaume
  • Garrido-Giménez, Carmen
Angiogenic factors; Preeclampsia; Uric acid, Factores angiogénicos; Preeclampsia; Ácido úrico, Factors angiogènics; Preeclàmpsia; Àcid úric, N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24+0 and 36+6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5-88.2) compared to 72.8% (95% CI 67.4-78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926-0.956) vs. 0.901 (95% CI 0.880-0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937-0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890-0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision., This work was supported by public funds obtained in competitive calls with peer review (grant PI19/00702), Insituto de Salud Carlos III, Spanish Ministry of Health, by the Maternal and Child Health and Development Network (SAMID, RD16/0022/0015), Instituto de Salud Carlos III, Madrid, Spain, the Spanish Clinical Research and Clinical Trials Platform, SCReN (Spanish Clinical Research Network), funded by the ISCIII-General Subdirectorate for Evaluation and Promotion of Research, through project PT13/0002/0028, integrated in the 2013–2016 R + D + I State Plan and co-financed by and the European Regional Development Fund (FEDER); and by the Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin Network (RICORS, RD21/0012/0001), Instituto de Salud Carlos III, Madrid, Spain, funded by the Recovery, Transformation and Resilience Plan 2017–2020, ISCIII, and by the European Union-Next Generation EU. Dr Cruz-Lemini is supported by Juan Rodés contract JR19/00047, Instituto de Salud Carlos III-Spanish Ministry of Health. Funding sources were not involved in study design, collection, analysis, and interpretation of data.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

The role of sex in the relationship between fasting adipokines levels, maximal fat oxidation during exercise, and insulin resistance in young adults with excess adiposity

  • Chávez-Guevara, Isaac A.
  • Amaro Gahete, Francisco J.
  • Osuna Prieto, Francisco J.
  • Labayen Goñi, Idoia
  • Aguilera, Concepción María
  • Ruiz, Jonatan R.
Aim: Previous evidence suggest that a sexual dimorphism in exercise fat oxidation and adipokines levels may explain a lower risk of cardio-metabolic disorders in women. Therefore, we investigated the role of sex in the relationship between adipokines levels, maximal fat oxidation (MFO) during exercise and insulin resistance. Methods: Fifty young adults with excess adiposity (31 women; body fat: 38.7 ± 5.3%) were included in this study. The fasting levels of leptin, adiponectin, glucose and insulin were determined from blood samples and the homeostatic model assessment of insulin resistance index (HOMA-IR) subsequently calculated. Body fat percentage and visceral adipose tissue (VAT) were assessed through dual-energy X-ray absorptiometry whereas MFO was estimated during an incremental-load exercise test after an overnight fasting through indirect calorimetry. Results: Men had lower levels of body fat (d = 1.80), adiponectin (d = 1.35), leptin (d = 0.43) and MFO (d = 1.25) than women. Conversely, men showed higher VAT (d = 0.85) and fasting glucose levels (d = 0.89). No sex differences were observed in HOMA-IR (d = 0.34). Adipokines levels were not associated with MFO in both sexes (r < 0.30), whereas adiponectin levels were inversely related with HOMA-IR in both men (r = −0.58) and women (r = −0.50). Leptin concentration was associated to HOMA-IR only in men (r = 0.41), while no statistically significant relationships were observed between MFO and HOMA-IR in both sexes (r < 0.44). Conclusion: Insulin resistance was similar between sexes regardless of superior levels of adipokines and MFO during exercise in women. Therefore, adiponectin and leptin may regulate glucose homeostasis without altering whole body fat oxidation rate during exercise., This study was funded by the Spanish Ministry of Economy and Competitiveness via the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III (PI13/01393; J.R.R.) and PTA-12264I, Retos de la Sociedad (DEP2016-79512-R; J.R.R.) and European Regional Development Funds (ERDF; J.R.R.), the Spanish Ministry of Education (FPU13/04365 (G.S.D), FPU14/04172 (F.A.G.) and FPU15/04059 (J.M.A.)), FJOP is supported by the Margarita Salas postdoctoral research contract programm (Ministry of Universities of Spain, European Union - NextGenerationEU) the Fundación Iberoamericana de Nutrición (FINUT; JRR), the Redes Temáticas de Investigación Cooperativa RETIC (Red SAMID RD16/0022; J.R.R.), the AstraZeneca HealthCare Foundation (J.R.R.), the University of Granada Plan Propio de Investigación 2016 -Excellence actions: Unit of Excellence on Exercise, Nutrition and Health (UCEENS) (J.R.R.), the Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades (ERDF; ref. SOMM17/6107/UGR; JRR), the Junta de Andalucía, Consejería de Economía, Conocimiento, Empresas y Universidad (ref. P18-RT-4455; J.R.R.) and by the CIBEROBN, Centro de Investigación Biomédica en Red (CB22/03/00058), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – European Regional Development Fund (J.R.R.).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Impact of 24-week supervised concurrent exercise on S-Klotho and vitamin D levels: a randomized controlled trial

  • Amaro Gahete, Francisco J.
  • Espuch-Oliver, Andrea
  • Cano-Nieto, Amalia
  • Alcántara Alcántara, Juan Manuel
  • García-Lario, José Vicente
  • Haro Muñoz, Tomás de
  • Llamas Elvira, José M.
  • Muñoz Torres, Manuel
  • Castillo, Manuel J.
  • Labayen Goñi, Idoia
  • Ruiz, Jonatan R.
This study aimed to investigate the effects 24 weeks of supervised exercise training at different intensities on S-Klotho and 25-hydroxyvitamin D plasma levels in young adults. This report was based on a secondary analysis from the ACTIBATE single-center unblinded randomized controlled trial (ClinicalTrials.gov ID: NCT02365129). A total of 144 young adults (~34% men and ~66% women) aged between 18 and 25 years took part in the study. The participants were randomly assigned to 3 different groups: (i) concurrent exercise training program based on the international physical activity recommendations at vigorous intensity (Ex-Vigorous group), (ii) at moderate intensity (Ex-Moderate group), and (iii) control group (no exercise). S-Klotho and 25-hydroxyvitamin D plasma levels were determined before and after the 24-week intervention programme. A significant decrease of 25-hydroxyvitamin D plasma levels were identified across time in all groups (p < 0.001), whereas no significant differences across time were observed in S-Klotho plasma levels (p = 0.497). There was no time x group interaction neither in S-Klotho nor in 25-hydroxyvitamin D plasma levels (all p > 0.7). In summary, our results showed that 24 weeks of supervised concurrent exercise training does not induce significant changes on S-Klotho and 25-hydroxyvitamin D independently of the exercise intensity in young adults., This study was funded by the Spanish Ministry of Economy and Competitiveness via the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III [PI13/01393; J.R.R.] and PTA-12264I, Retos de la Sociedad[DEP2016-79512-R; J.R.R.] and European Regional Development Funds(ERDF; J.R.R.), the Spanish Ministry of Education (FPU14/04172 (F.A.G.) andFPU15/04059 (J.M.A.)), the Fundación Iberoamericana de Nutrición (FINUT;JRR), the Redes Temáticas de Investigación Cooperativa RETIC (Red SAMIDRD16/0022; J.R.R.), the AstraZeneca HealthCare Foundation (J.R.R.), the University of Granada Plan Propio de Investigación 2016 -Excellence actions: Unit of Excellence on Exercise and Health (UCEES) (J.R.R.), the Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades (ERDF; ref. SOMM17/6107/UGR; JRR), the Junta de Andalucía, Consejería de Economía, Conocimiento, Empresas y Universidad (ref. P18-RT-4455; J.R.R.), the Juan de la Cierva-Formación Grant funded by MCIN/AEI/ 10.13039/501100011033 and by 'EuropeanUnion NextGenerationEU/ PRTR' (Ref. FJC2020-044453-I; J.M.A.).